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Abstract
Background: Cannabis is the most widely used illicit substance by Australian young people, including those
engaged with youth alcohol and other drug (AOD) systems. While recreational cannabis use in young people may
be a developmental activity for some, for others, this usage becomes regular and be associated with poorer long
term outcomes. This study reports on the rates of cannabis use and co-existing psychosocial complexity factors in
the Youth Needs Census (2013 and 2016) where workers report on all clients in the youth AOD system, a cohort
considered highly vulnerable.
Methods: Data was examined for two rounds of data collection for the Youth Needs Census, including 823 youth
AOD service engaged young people in 2016 and 1000 AOD service engaged young people in 2013, to identify
usage rates, psychosocial outcomes, and changes over time.
Results: Daily use of cannabis alone significantly exceeded daily usage rates for methamphetamines, alcohol, and
cannabis used alongside other substances. Daily cannabis use was significantly associated with mental health
problems, employment problems, education problems, family problems, and housing problems. Daily cannabis use
was associated with most psychosocial complexity factors to the same extent as daily methamphetamine use and
daily alcohol use, with daily cannabis users only showing lower incidence of the drug-related harm measure.
Notably, daily cannabis use also increased from 2013 (47.5%) to 2016 (54.2%).
Conclusions: It is imperative that the number of individuals using cannabis is considered alongside the severity of
harm when assessing the social impact of this substance. Within cannabis users engaged with the youth AOD
system, who often have high levels of psychosocial complexity, cannabis is used daily by a large proportion of
these youths and may play a role in negatively impacting their lives.
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Background
In the Australian Institute of Health and Welfare
(AIHW) National Drug Strategy Household Survey
(NDSHS) 2013 [1], cannabis was found to be the most
prevalent illicit drug used, with 35% of people aged 14
or older reporting lifetime use while 10.2% of people had
used cannabis in the previous 12 months. Cannabis
usage was most prevalent in people aged between 14
and 29, and of those in this age range who used
cannabis, 45% had used at least monthly, making canna-
bis the most frequently used drug [1]. The increasing
use of cannabis over time is being debated, with some
older data indicating rises in use (9.1% of people over
14 years of age in 2007 to 10.3% in 2010) [1] whilst other
data suggests relatively stable use in Australia, if not de-
clining use for younger age groups [2].
Evidence indicates that a complex range of social, fam-
ily, peer, and personal elements influence the substance
use patterns of adolescents and young adults [3]. Cumu-
lative exposure to violence in the family, school, and
community significantly increases the risk of both alco-
hol and cannabis use in young people [4], and evidence
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indicates that psychosocial disadvantage may both be a
risk factor for cannabis use specifically, as well as an out-
come in those who commence use at an early age (prior
to 16) [5]. Within the home, evidence indicates that fam-
ily instability and parental substance use increase the
chance of engaging in cannabis use in adolescents [6]. In
relation to psychological coping and cannabis use,
Hyman and Sinah [7] highlighted the relationship be-
tween the experience of stress, negative life events and
trauma and cannabis use. Moreover, this research team
indicated that whilst many individuals will use cannabis
recreationally, a subset of people will develop chronic is-
sues to manage chronic stress as a coping method. Trau-
matic experiences such as physical and sexual abuse in
young people may place an individual at increased vul-
nerability to cannabis use to cope with negative feelings
[8]. Likewise, structural factors such as housing instabil-
ity may increase both use and risky behaviour associated
with use [9]. Evidence from a longitudinal study in
Christchurch, New Zealand highlights the association
between cannabis use and worsened employment and
educational attainment [5]. Hall [10] indicated that regu-
lar cannabis use doubles the risk for early school leaving
and increases risks of mental health concerns. While
many individuals experiment with cannabis use, evi-
dence indicates that chronic users in particular are at
high risk of unemployment in later life after controlling
for psychosocial complexity covariates [11]. Overall, data
from numerous participant pools indicate both complex
psychosocial precipitants and outcomes of heavy use,
chronic use, or early age of use onset.
Age of first use of cannabis is proposed to be an im-
portant factor in determining progression to heavy or
problematic use [12–15]. Adolescence is a critical nexus
where fundamental stages of neurological development
and refinement occur alongside physical, social, and
emotional development [16, 17]. Emerging data indicates
that most mental health issues are associated with devi-
ation from normal healthy developmental trajectories
[18]. Even subtle changes in brain development during
these time windows may occur due to substance use,
and contribute to functional changes that persist
throughout life [19, 20]. As such, adolescence is a high-
risk period when a number of psychiatric and patho-
physiological issues can arise, including major depressive
disorder, bipolar disorder, anxiety disorders and schizo-
phrenia [21]. Cannabis use in adolescence has specific-
ally been associated with a range of negative impacts to
mental health and psychosocial development for those
with underlying vulnerability [22], especially in those
predisposed to psychosis [23–26].
Whilst many occasional users have no long term conse-
quences of cannabis use, evidence indicates poorer out-
comes in heavy users. The associated functional impacts of
regular cannabis use may be significant [27, 28]. Research
indicates heavy adolescent cannabis users show persistent
and enduring neurocognitive deficits in learning and mem-
ory related to heavy cannabis use [29], and these are more
pronounced in comparison to adults [30]. These cognitive
changes may be associated with psychosocial development
difficulties, including disengagement with education and/or
employment [5]. In Australia, young people with concerns
over alcohol and/or substance use are referred to the youth
alcohol and other drug (AOD) services/system to support
them to manage their substance use, reduce harms and
make connections with services and supports to foster psy-
chosocial resilience. Young people engage with the Youth
AOD system through self or other-referral when they (or
others) consider substance use to be having a detrimental
impact upon their lives. AOD services include counselling,
case management, youth work, group work, residential and
home detoxification programs and long residential rehabili-
tation facilities, with many young people getting a mix of
these interventions. These young people may be disengaged
from work and education, lack stable accommodation, and
have significant psychosocial complexity compared with
many other young people. Because of these factors, they are
often under-represented in large scale government survey-
ing and research into the psychosocial concomitants of sub-
stance use in this group is under-represented [31].
The aim of the present study was to examine the
prevalence of cannabis use in young people engaged
with youth (AOD) services, and to investigate the
psychosocial complexity factors present in this cohort,
including how they have changed over time. Metham-
phetamine use and alcohol use were analysed for
comparison with cannabis use. Five hypotheses were
formed based on AIHW usage data from the general
population and empirical findings: (1) Cannabis would
be more commonly and frequently used than other
substances; (2) Daily cannabis use would be associated
with mental health problems, drug-related harm, sui-
cidality, employment problems, education problems,
criminality, family problems, and housing problems;
(3) These psychosocial complexity factors would be
associated with daily cannabis use to a similar or
greater extent than daily methamphetamine or alcohol
use; (4) Daily cannabis use would have increased in
frequency between the 2013 and 2016 census periods;
and (5) The psychosocial complexity factors associ-
ated with daily cannabis use would have increased in
frequency between 2013 and 2016.
Method
Participants
The Youth Needs Census (ThYNC) was collected in 2013
and 2016 across Victorian youth AOD services. The 2013
sample collected surveys on 1000 young people and the
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2016 collection reported on a further 823 young people.
In 2013, the average age of the sample was 18.93 years
(SD = 2.82 years), with ages ranging between 8 and 27
years. Only 3 individuals were over 25 years of age. The
sample included 339 females, 665 males and 6 transsexual
young people. The 2016 sample was characterized by an
average age of 18.84 years (SD = 2.74 years), with ages ran-
ging between 10 and 27 years. Notably, only 5 individuals
were over 25 years of age. The sample included 294 fe-
males, 522 males, 5 transsexual young people and 2 indi-
viduals who did not nominate a gender identity (an option
available in the latter census).
Materials
ThYNC was comprised of 56 items relating to sub-
stances used (in past month, daily or almost daily,
substance of concern, substance of treatment focus,
substance dependence, etc.). This was followed by an
assessment of service utilization (programs used,
length of service, etc). The survey then went on to
review demographic and psychosocial complexity is-
sues experienced by the young person. These com-
plexity factors in these young people included: (i)
mental health problems (including non-suicidal self-
injury and suicide attempts); (ii) drug-related harm
(e.g., physical injury); (iii) engagement in employment
or education; (iv) criminal and forensic issues (exclud-
ing criminal offences directly resulting from drug pos-
session and distribution); (v) family problems (e.g.,
abuse, neglect, domestic violence); and (vi) housing
instability. These psychosocial complexity factors were
further investigated using associated sub-questions, in-
cluding items querying the experiences of verbal,
physical, and sexual abuse, as well as neglect; and ex-
periences of criminal violence and family violence.
ThYNC also included Section 2 (Items I, J, and K) of
the Australian Treatment Outcome Profile (ATOP), a
collection of questions designed to measure an indi-
vidual’s level of psychological wellbeing, physical well-
being, and quality of life on a standardized 10-point
scale [32]. The ATOP shows strong validity and reli-
ability in AOD samples [32].
Procedure
The Youth Needs Census is a three-yearly activity in which
all participating Victorian youth AOD sector workers
complete a census survey on each client they are working
with (most recently conducted in 2016 in Victoria). One
survey was conducted on each young person enrolled in
the youth AOD system on the census date. The ThYNC
project received ethics approval from the Eastern Health
Human Research Ethics Committee in 2013 (E28–1213)
and 2016 (LR89/2016). All participants provided informed
consent by reading a participant information and consent
form before completing each survey online. Workers that
did not provide informed consent were taken to an auto-
matic thank you page and exited from the survey.
To complete ThYNC, all workers were informed of
the upcoming census date and provided a link to an on-
line survey offered using the Qualtrics software package
(Qualtrics, Utah, USA). Managers were asked to monitor
completion at their sites but records were not obtained
on the number of surveys completed in each service to
ensure the voluntary nature of the study for youth
workers and services. The Youth Needs Census (2013
and 2016) was a 56-item clinician rated multiple choice
audit tool [31]. ThYNC was completed by youth and
health workers across Victorian Youth AOD services to
report on every client in their caseload on a statewide
census date. Services generated client lists on this nomi-
nated date (6 June in 2013 and 21 November in 2016)
indicating a total eligible sample pool. A total of 36 ser-
vices or service sites participated in 2013 and 28 services
or service sites participated in 2016. Based on sample
pool, 84% of eligible young people were reported on in
2013 and 96% in 2016. Upon completion, the Qualtrics
database was exported to the Statistical Package for the
Social Sciences (SPSS), Version 21. Cleaning and analysis
of the data was then performed using SPSS.
Data analysis strategy
Four variables were available as potential identifiers of
problematic substance use: (i) daily or almost daily use;
(ii) use within the past month; (iii) worker identification
of young person as substance dependent; and (iv) worker
identification of the substance of primary concern (i.e.,
treatment focus). Daily use, use in the past month, and
dependence were coded yes or no, and were not mutu-
ally exclusive with other substances (e.g., an individual
could be reported to use both cannabis and metham-
phetamine daily). Substance of primary concern was
rated by substance, forming independent groups (e.g.,
cannabis, methamphetamines, or alcohol).
Daily or almost daily cannabis use was selected as the
primary focus of hypothesis-testing, due to this variable
most objectively capturing high frequency of use. Past
month usage was judged to be less indicative of high fre-
quency use, whilst dependence was not used as a meas-
ure as it was not determined using structured clinical
tools and was not included in the 2013 ThYNC. The
substance of primary concern variable was not included
as it did not allow for acknowledgement of poly-
substance use and was determined solely on clinician
opinion. Past month usage, dependence, and substance
of primary concern were however retained as inform-
ative in describing the sample.
Methamphetamines and alcohol were chosen for
cross-substance comparison of psychosocial complexity
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factors. This was because cannabis, methamphetamines,
and alcohol were the three most frequent substances of
daily use in both the 2016 (54.2, 12.6, and 16.8% re-
spectively) and 2013 samples (46.3, 10.4, and 17.8% re-
spectively), excluding tobacco. Tobacco products were
very commonly used (43.0% in 2016, 44.1% in 2013),
but were not investigated in the present study as they
were seldom identified as a primary concern (2.7% in
2016, 3.1% in 2013) in youth services clients. No other
substance exceeded 5% of the sample in terms of daily
use, dependence, or substance of primary concern.
The majority of ThYNC data was categorical in nature.
For this reason, non-parametric testing was the most ap-
propriate form of inferential statistics. Hypothesis-
testing was conducted by generating contingency tables
and deriving chi-square as the omnibus test, with re-
sponses of “other” or “unsure” excluded from analysis
[33]. Cramer’s V was calculated to estimate effect size
[33]. The significance threshold was set at p < .05. Bon-
ferroni correction was not applied due to concerns that
it would be overly conservative given the categorical na-
ture of the data [34]. Initial descriptive statistics for the
sample were run using daily use, past month use, de-
pendence, and primary concern data as collected. Fol-
lowing this, in order to acknowledge poly-substance use
and facilitate group comparison, the daily use variables
for cannabis, methamphetamines, and alcohol were ag-
gregated into a single variable containing five groups: (i)
no daily substance use (n = 295); (ii) daily use of canna-
bis only (n = 309); (iii) daily use of cannabis as well as
methamphetamines, alcohol, or all three substances (n =
137); (iv) daily use of methamphetamines only (n = 35);
and (v) daily use of alcohol only (n = 41). Cases of daily
use of both methamphetamines and alcohol (n = 6) were
excluded as this substance combination was not a focus
of the study and the group size was minuscule.
Results
Frequency of cannabis use
Figure 1 demonstrates that there were a greater propor-
tion of daily cannabis use cases (54.2%) than daily meth-
amphetamines (12.6%) or alcohol use cases (16.8%).
Similarly, cases of past month cannabis use were more
frequent (66.6%) than for methamphetamines (29.5%) or
alcohol (53.1%). Youth workers indicated that 48.2% of
the young people they were working with at the time of
the census could be considered dependent on cannabis
based on their clinical experience, and cannabis was the
primary drug of concern in 52.3% of cases. This was a
greater proportion of young clients than were dependent
on methamphetamines or alcohol (13.0 and 10.9% re-
spectively), or for whom methamphetamines or alcohol
were the primary drug of concern (31.2 and 16.5%
respectively). Daily cannabis use was not disproportion-
ately represented by gender, Χ2(2) = 2.50, p = .287, Cra-
mer’s V = .06, sexual orientation, Χ2(1) = 0.22, p = .639,
Cramer’s V = .02, Aboriginal and Torres Strait Islander,
Χ2(1) = 1.03, p = .310, Cramer’s V = .04, or asylum-seeker
demographics, Χ2(1) = 0.48, p = .489, Cramer’s V = .02.
Fig. 1 Case percentages for daily use, monthly use (past 4 weeks), dependence, and being the substance of primary concern across cannabis,
methamphetamines, and alcohol
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Overlap in daily or almost daily substance use was present,
with 14.1% of young people engaging in daily cannabis also
using methamphetamines daily, Spearman’s ρ(n= 823) = .05,
p= .162, whilst 20.4% also used alcohol, Spearman’s ρ(n=
823) = .11, p= .002. In the past month, 33.0% of young
people engaging in daily cannabis use had used metham-
phetamines, Spearman’s ρ(n= 823) = .08, p= .019, whilst
59.6% had also used alcohol, Spearman’s ρ(n = 823) = .14,
p < .001. With regards to dependence, 84.8% of young
people engaging in daily cannabis use were rated as
dependent on cannabis, Spearman’s ρ(n= 823) = .80,
p > .001, whilst 13.0% were dependent on methamphet-
amines, Spearman’s ρ(n = 823) < .01, p= .998, and 12.3%
were dependent on alcohol, Spearman’s ρ(n= 823) = .05,
p= .163. Cannabis was the primary substance of concern for
65.2% of young people engaging in daily cannabis use, with
methamphetamines and alcohol the primary substance of
concern for 19.1 and 7.2% respectively, Χ2(1) = 148.59,
p > .001, Cramer’s V= .46.
Comparison of substance use categories
A visual comparison of group numbers is displayed in
Fig. 2. There were significantly more cases of daily
cannabis use than there were daily use cases of canna-
bis plus other substances, methamphetamines only, or
alcohol only, Χ2(4) = 432.58, p > .001, supporting the
first hypothesis. Figure 3a compares psychosocial
complexity factors proportionately across the five sub-
stance use categories. Young people using cannabis
daily were significantly more likely than young people
not engaging in daily substance use to experience
mental health problems, Χ2(1) = 7.32, p = .007, Cra-
mer’s V = .12, employment problems, Χ2(1) = 4.63,
p = .032, Cramer’s V = .09, education problems,
Χ2(1) = 12.09, p = .001, Cramer’s V = .15, family prob-
lems, Χ2(1) = 10.04, p = .002, Cramer’s V = .13, and
housing problems, Χ2(1) = 4.83, p = .028, Cramer’s
V = .09, supporting the second hypothesis.
Notably, the rate of mental health problems in daily
cannabis users included a 37.9% rate of formal diagnosis
of a mental health condition. In terms of the past experi-
ences of young people using cannabis daily, the data in-
dicated that these young people had high lifetime
histories of neglect (39.9%), emotional abuse (51.1%),
physical abuse (39.5%), sexual abuse (15.5%) and being
victims of violent crime (24.4%). In relation to family
violence more specifically, young people using cannabis
were reported to have witnessed family violence in
35.2% of cases, experienced as the victim of family vio-
lence in 34.3% and the instigator of family violence in
18.2% of cases. Daily cannabis use was weakly negatively
associated with psychological wellbeing, Spearman’s
ρ(n = 823) = −.17, p < .001, physical wellbeing, Spear-
man’s ρ(n = 823) = −.20, p < .001, and overall quality of
life, Spearman’s ρ(n = 823) -.19, p < .001. Elaborating on
the first hypothesis test, these data further indicate an
association between cannabis use and poorer mental and
physical health.
Fig. 2 Separated case numbers for no daily substance use and daily use of cannabis, cannabis plus methamphetamines and/or alcohol,
methamphetamines only, or alcohol only
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To test the third hypothesis, the proportion of each psy-
chosocial complexity factor was compared across cases of
daily cannabis use only, daily methamphetamine use only,
and daily alcohol use only. No significant differences be-
tween the three substances were present for mental health
problems, suicidality, employment problems, education
problems, criminality, family problems, or housing prob-
lems, although young people engaging in daily use of canna-
bis only were significantly less likely to experience drug-
related harm, Χ2(2) = 15.10, p= .001, Cramer’s V= .21.
These results support the third hypothesis.
To acknowledge the occurrence of poly-substance use,
where an individual may engage in the use of multiple sub-
stances on a daily basis, as well as the low number of young
people using only methamphetamines or alcohol daily,
cases of daily use of cannabis only were compared to cases
of daily use of cannabis plus methamphetamines and/or al-
cohol in terms of psychosocial risk factors. Young people
a
b
Fig. 3 a Percentage of young people affected by psychosocial complexity factors across cases of no daily substance use and daily use of
cannabis, cannabis plus methamphetamines and/or alcohol, methamphetamines only, or alcohol only. b Number of young people affected by
psychosocial complexity factors across cases of no daily substance use and daily use of cannabis, cannabis plus methamphetamines and/or
alcohol, methamphetamines only, or alcohol only
Reichelt et al. BMC Psychiatry          (2019) 19:416 Page 6 of 11
combining daily use of cannabis with daily use of metham-
phetamines and/or alcohol were significantly more likely to
experience drug-related harm, Χ2(1) = 23.89, p < .001, Cra-
mer’s V = .25, suicidality, Χ2(1) = 4.00, p < .045, Cramer’s
V = .11, employment problems, Χ2(1) = 5.96, p < .015, Cra-
mer’s V = .12, and education problems, Χ2(1) = 4.89,
p < .027, Cramer’s V = .11. No significant differences were
present for mental health problems, criminality, family
problems, or housing problems.
The above hypothesis tests measured strength of associ-
ation by analysing the proportion of psychosocial complexity
factors relative to group size. This approach allowed infer-
ences to be drawn regarding the likelihood of individual risk
based on substance use category, but does not consider the
greater prevalence of cannabis use. Figure 3b expresses the
same data shown in Fig. 3a as number of participants, rather
than as percentage of substance use group. Comparing the
mean number of people impacted across the eight psycho-
social complexity factors, the amount of young people using
cannabis daily affected was 3.49:1 of those using metham-
phetamines daily, and 2.86:1 of those using alcohol daily,
providing a metric of the broader social impact of cannabis
use beyond individual risks.
Comparison of 2016 and 2013 cohorts
The 2016 and 2013 cohorts did not significantly differ in
age or gender. The proportion of young people using
cannabis daily significantly increased to 54.2% in 2016
from 47.5% in 2013, Χ2(1) = 8.09, p = .004, Cramer’s
V = .07. There were no significant changesin daily meth-
amphetamine use or daily alcohol use between 2016 and
2013. Cannabis use in the past month remained stable
between 2016 and 2013, however there were significantly
less cases of use in the past month for both methampe-
tamines, 29.5% versus 34.9% respectively, Χ2(1) = 5.95,
p = .015, Cramer’s V = .06, and alcohol, 53.1% versus
63.1% respectively, Χ2(2) = 18.61, p < .001, Cramer’s
V = .10. Dependence was not assessed in the 2013 sam-
ple. Cannabis was identified as the primary substance of
concern in a greater proportion of cases in 2016, up to
52.3% in 2016 from 44.4% in 2013. Methamphetamines
as primary concern increased only slightly between co-
horts, 31.2% in 2016 versus 30.0% in 2013. The increase
in young people for whom cannabis was a concern was a
result of displacing individuals for whom alcohol was the
primary concern, with alcohol as primary concern de-
creasing to 16.5% in 2016 from 25.6% in 2013. These fre-
quency changes in primary substance of concern were
significant, Χ2(2) = 19.56, p < .001, Cramer’s V = .11.
Investigating the fourth hypothesis, Fig. 4 compares
young people using cannabis daily who were assessed in
the 2016 ThYNC survey to those assessed in the 2013
ThYNC survey. Young people using cannabis daily in
2016 exhibited significantly higher rates of mental health
problems, Χ2(1) = 29.44, p < .001, Cramer’s V = .13, and
disengagement from education, Χ2(1) = 4.86, p = .028,
Cramer’s V = .05, but a significantly lower rate of current
criminal behaviour, Χ2(1) = 13.04, p < .001, Cramer’s
V = .09. Rates of drug-related harm, suicide attempt
Fig. 4 Comparison of cases of daily cannabis use experiencing psychosocial complexity factors across 2016 and 2013 cohorts
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presence, disengagement from employment, family prob-
lems, and housing problems remained stable between
2013 and 2016 in young people who were using cannabis
daily.
Discussion
This study examined cannabis use and psychosocial
complexity factors in young people engaged with youth
AOD services in 2016 and 2013. The results provide a
picture of the impact that daily cannabis use has on
young people accessing youth AOD services. As pre-
dicted in the first hypothesis, cannabis was found to be
the most common substance of daily use, both on its
own and in combination with other substances. Support-
ing the second hypothesis, cannabis use in young people
was associated with elevated rates of mental health prob-
lems, disengagement from employment, disengagement
from education, family problems, and housing problems.
Mental health problems, suicidality, employment prob-
lems, education problems, criminality, family problems,
and housing problems were present with daily cannabis
use at a similar rate to their co-occurrence with daily
methamphetamine and alcohol use, supporting the third
hypothesis, although drug-related harm, suicidality, em-
ployment problems, and education problems were exac-
erbated when daily cannabis use was accompanied by
daily use of another substance. In accord with the fourth
hypothesis, the proportion of young people using canna-
bis daily had significantly increased between 2013 and
2016, although only mental health problems and disen-
gagement from education worsened in frequency be-
tween 2013 and 2016.
The major finding of this study was that cannabis was
the most frequent substance of daily use, monthly use,
dependence, and primary concern in young people
accessing youth AOD services. Rates of cannabis use
were more than double the rates of methamphetamine
and alcohol use in this sample, and this overwhelmingly
higher prevalence of daily cannabis use was maintained
even when daily use of cannabis and other substances
was considered separately. These findings indicate that
cannabis prevalence in individuals accessing youth AOD
treatment has now overtaken that of alcohol, a legally
accessible substance that was more commonly used than
cannabis in the previous ThYNC census, and also show
that despite widespread media coverage of metham-
phetamine problems [e.g., 35, 36], cannabis is a far more
prevalent and problematic concern.
Daily cannabis use was associated with a range of
psychosocial complexity factors, in a similar fashion
that methamphetamines and alcohol were problematic
for these young people. Only drug-related harm was
proportionately more likely for young people using
methamphetamines or alcohol daily as opposed to
cannabis. Drug-related harm, suicidality, employment
problems, and education problems were exacerbated
when cannabis was used daily alongside other sub-
stances. Notably, these findings indicate that cannabis
use in youths engaged with the youth AOD system in
Victoria have significant negative personal, family and
societal impact on young people. With half of youths
engaged with youth AOD services using cannabis
daily with the majority of these young people experi-
encing negative consequences, this highlights the
complex social issue around effectively supporting
young people with cannabis as the substance of con-
cern. Indeed, when examined in terms of the number
of people affected, individuals using cannabis daily
constitute a significantly larger amount of young
people experiencing psychosocial complexity factors
than do those using alcohol or methamphetamines.
Supporting young people presenting with daily canna-
bis use is therefore responsible for greater consump-
tion of services.
Importantly, cannabis use is also an increasing con-
cern, with daily use increasing by 6.7% between the 2013
and 2016 censuses, with the data suggesting that increas-
ing cannabis use was displacing alcohol use in young
people accessing youth services. The degree to which
daily cannabis use was linked to the eight psychosocial
risk factors examined by the present study largely
remained stable since 2013. This means that for the past
3 years, most psychosocial concerns have not increased
in prevalence in disadvantaged youth who use cannabis
daily. However, both mental health problems and disen-
gagement from education have worsened since 2013,
with criminality lessening. It is timely when considering
cannabis use and psychosocial complexity that ThYNC
is an association study so there is no implication that in-
creasing rates and level of cannabis use predict psycho-
social complexity, nor that this complexity is predictive
of cannabis use. Rather the study highlights to clinicians
and researchers that there is often high rates of psycho-
social complexity in young people engaged with AOD
services who use cannabis on a daily basis [37]. This
interdependency is expected when viewing substance
use through the resilience [38] and developmental per-
spectives [39] adapted by youth AOD services where in-
dividual, family and systems concepts must be included
into acre planning and treatment. .
The findings should be qualified in the context of limi-
tations to the present research. Firstly, the categorical
nature of the present data hindered parametric analysis.
As a large survey that is sub-population-scale in scope,
ThYNC questions are typically rated in dichotomous
(yes-or-no) format, sometimes including an “other” or
“unsure” option, with a focus on being as clearly defined
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and objective as possible for workers. This method of
data collection meant that potentially useful quantitative
metrics allowing for more rigorous statistical analysis
(e.g., quantity of daily use, method of administration,
etc.) were not available. Similarly, the large-scale nature
of data collection for this study precluded the use of
more involved standardised measures with established
reliability and validity.
A second limitation was that the chi-square tests used
to analyse the data identify an association, but do not as-
sess cause. The eight psychosocial risk factors that were
examined feasibly have a bidirectional relationship with
substance use. Accordingly, these factors may have led
to individuals seeking treatment from youth AOD ser-
vices [40], or might have arisen from a common predis-
posing variable, such as a pre-existing predisposition to
mental health problems [41]. In treating substance
abuse, it is important to not just view these psychosocial
complexity factors as probable outcomes, but to also ac-
knowledge them as important precipitants that can be
made a focus of treatment [15].
Thirdly, while not a limitation as such, it is important
to qualify the scope of the present research. This study
made use of two large-scale data sets recorded from
youth AOD workers about the young people that they
were working with. This means that the population be-
ing studied here are those accessing youth AOD services,
with the large sample size and pattern of results indicat-
ing that cannabis use is an issue that should not be ig-
nored in this population. However, these results may not
generalise to the general population that is of interest
when further quantifying the social impact of cannabis
use. These data specifically relate to the issues surround-
ing youths who are presenting and engaging with youth
AOD services, not a general measure of the impacts of
cannabis youth in the general population. Whilst this
limits generalizability to the wider youth community of
Australia, this is deliberate focus. The results of both
ThYNC surveys indicate that these young people are
often disengaged with school and work, in unstable
housing and experiencing other factors that make them
less likely to be captured in large scale data collection ef-
forts [e.g., 1, 2]. ThYNC acknowledges these young
people are towards the edge of the typical pool of young
people in terms of substance use and life circumstances
(sometimes referred to as the “pointy end” of youth sub-
stance use) and that this survey methodology is deliber-
ately developed to provide these young people with an
advocacy and research voice. As the research only cap-
tured young people engaged with services, it is recog-
nized that many more young people with similar levels
of use do not engage with youth AOD services who do
experience significant concerns. This highlights the need
for services to be attuned and accessible to as many
young people across the spectrum of substance use as
possible.
Globally, mental, neurological and substance use dis-
orders contribute to a significant proportion of disease
burden [42]. However, data from the World Mental
Health Surveys (WMHS) suggest that only a small mi-
nority (7.1%) of people with substance use disorders re-
ceive even minimally adequate treatment [43]. The
present study has contributed to continuing debate
about the importance of being aware of and complexity
in managing cannabis use in young people. The findings
underscore the need to remember that daily cannabis
use is associated with a range of negative outcomes in
these youths, and also that recovery from substance use
disorders is highly possible made if people can access
engaging and evidence-informed treatment services and
social supports [44, 45]. Cannabis use is associated with
detrimental psychosocial complexity factors to a similar
extent as use of methamphetamines and alcohol, and the
sheer prevalence of daily use makes cannabis a substance
of concern from an epidemiological, social, personal and
economic perspective.
Conclusion
The association between regular cannabis use and
psychosocial complexity has important clinical ramifi-
cations. For clients presenting with regular cannabis
use, clinicians may benefit form exploring their ex-
perience of psychosocial complexity. Likewise, in
people presenting with clear psychosocial complexity,
screening for cannabis use may prove important and
require consideration in the case formulation. Overall
this research again highlights that systematic assess-
ment of substance use in AOD help-seeking young
people is important in any debate around cannabis,
particularly those considering the issues from devel-
opmental and harm minimization perspectives.
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